Xenetic Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.78 | -$0.78 | -$0.78 |
| Q2 2024 | 0 | -$0.83 | -$0.83 | -$0.83 |
| Q3 2024 | 1 | -$0.14 | -$0.14 | -$0.14 |
| Q4 2024 | 0 | -$0.20 | -$0.20 | -$0.20 |
Xenetic Biosciences, Inc. Earnings Date And Information
Xenetic Biosciences, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.83 earnings per share for the quarter, missing analysts' consensus estimates of $-0.83 by $0. The company had revenue of 726,404 for the quarter and had revenue of 2.54 M for the year. Xenetic Biosciences, Inc. has generated $-3 earnings per share over the last year ($-2.71 diluted earnings per share) and currently has a price-to-earnings ratio of -1.25. Xenetic Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Xenetic Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$0.83 | -$0.83 | 0 | $540,000 | $726,404 |
| 05/09/2024 | Q1 2024 | -$0.79 | -$0.78 | 0.01 | $510,816 | |
| 04/26/2024 | Q4 2023 | -$0.76 | $671,963 | |||
| 11/09/2023 | Q3 2023 | -$0.69 | $460,000 | $611,174 | ||
| 08/10/2023 | Q2 2023 | -$0.69 | $440,000 | $651,005 | ||
| 05/11/2023 | Q1 2023 | -$1.10 | -$0.53 | 0.57 | $605,844 | |
| 04/28/2023 | Q4 2022 | -$0.91 | $486,972 | |||
| 11/09/2022 | Q3 2022 | -$0.05 | $410,000 | $414,250 | ||
| 08/11/2022 | Q2 2022 | -$0.19 | $416,710 | |||
| 05/12/2022 | Q1 2022 | -$1.10 | -$0.11 | 0.99 | $388,993 | |
| 03/22/2022 | Q4 2021 | -$0.15 | -$0.18 | -0.03 | $332,604 | |
| 11/12/2021 | Q3 2021 | -$1.20 | -$1.33 | -0.13 | $200,000 | $349,269 |
| 08/12/2021 | Q2 2021 | -$1.60 | -$1.30 | 0.3 | $290,000 | $287,603 |
| 05/11/2021 | Q1 2021 | -$1.54 | $191,216 | |||
| 03/16/2021 | Q4 2020 | -$0.20 | -$0.14 | 0.06 | $151,332 | |
| 11/12/2020 | Q3 2020 | -$0.18 | -$12.01 | -11.83 | $127,000 | $115,934 |
| 08/12/2020 | Q2 2020 | -$2.20 | -$1.52 | 0.68 | $60,000 | $112,927 |
| 05/14/2020 | Q1 2020 | -$3.70 | -$1.89 | 1.81 | $56,749 | |
| 03/26/2020 | Q4 2019 | -$0.38 | -$0.19 | 0.19 | $17,066 | |
| 11/14/2019 | Q3 2019 | -$23.04 | $0 |
Xenetic Biosciences, Inc. Earnings: Frequently Asked Questions
-
When is Xenetic Biosciences, Inc.'s earnings date?
Xenetic Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
How can I listen to Xenetic Biosciences, Inc.'s earnings conference call?
The conference call for Xenetic Biosciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Xenetic Biosciences, Inc.'s conference call transcript?
The conference call transcript for Xenetic Biosciences, Inc.'s latest earnings report can be read online.
-
How much revenue does Xenetic Biosciences, Inc. generate each year?
Xenetic Biosciences, Inc. (:XBIO) has a recorded annual revenue of $2.54 M.
-
How much profit does Xenetic Biosciences, Inc. generate each year?
Xenetic Biosciences, Inc. (:XBIO) has a recorded net income of $2.54 M. Xenetic Biosciences, Inc. has generated $-2.71 earnings per share over the last four quarters.
-
What is Xenetic Biosciences, Inc.'s price-to-earnings ratio?
Xenetic Biosciences, Inc. (:XBIO) has a price-to-earnings ratio of -1.25 and price/earnings-to-growth ratio is -0.03.
